Free Credits Available Through 9/15/2026 - This is a special on-demand version of this course.

This course is designed for pharmacists and pharmacy technicians who want an overview of the epidemiology of hepatitis A, B, and C viruses, including transmission, prevention, and those at increased risk of infection.  Current hepatitis A and B vaccine recommendations along with considerations for vaccine service integration including infrastructure and workflow. Other barriers to providing viral hepatitis pharmacy services will be addressed, such as billing insurance and special considerations required for patients with co-occurring conditions (specifically, HIV/AIDS), social drivers of health, and substance use disorders. Patient and pharmacy-related education resources will be provided. Priority registration is given to individuals licensed in Philadelphia. 

CEUs Available: 1.5 Pharmacy CEs

Faculty: Elissa Devenny, PharmD, CSP Pharmacy Manager, Director of Clinical Services at Sunray Specialty Pharmacy 

Learning Objectives:

1. Describe the mechanism by which hepatitis A (HAV), hepatitis B (HBV), and hepatitis C (HCV) are transmitted.
2. Identify appropriate treatment for patients with hepatitis B and hepatitis C, including patients with HIV co-infection.
3. Utilize ACIP recommendations to promote hepatitis A and B vaccinations to patients.
4. Implement immunization services at community pharmacy locations.
5. Locate immunization-related resources from PDPH.

Program Code: 24-HF-14-W2

ACCREDITATION STATEMENT:                                                                                                                                                                        

In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and MidAtlantic AIDS Education and Training Center of the Health Federation of Philadelphia American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Pharmacists

This activity provides 1.5 ACPE contact hours (0.15 CEUs) of continuing education credit. Universal Activity Number. Knowledge

Other HCPs

Other members of the care team will receive a certificate of participation.

Disclosures

According to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and any relevant financial relationships listed for these individuals have been mitigated.

Faculty

Elissa Devenny, PharmD: No relevant financial relationships with ineligible companies to disclose.

Planning Committee

Debra D’Alessandro, MPH; John JD Juchniewicz, MCIS, CHCP, FACEHP; Eleanor DeShields; Lane Taylor, MPH: No relevant financial relationships with ineligible companies to disclose.

This activity will not review off-label or investigational information.

The opinions expressed in this accredited continuing education activity are those of the faculty, and do not represent those of the Academy or MidAtlantic AIDS Education and Training Center of the Health Federation of Philadelphia This educational activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically and draw conclusions only after careful consideration of all available scientific information.

FUNDING ACKNOWLEDGMENT: This program is supported by a grant from the Health Resources and Services Administration (HRSA), HIV/AIDS Bureau, Office of Program Support, #U1OHA29295; and Centers for Disease Control and Prevention via Philadelphia Department of Public Health.

Instructions on How to Receive Credit:

There are no fees to participate in the activity. Participants must log on and participate in the live activity. To receive CME/CNE credit for your participation, please complete the post-assessment/evaluation. Your statement of credit will be issued through CPE Monitor in 6-8 weeks. Only pharmacy learners who provided valid NABP e-Profile ID numbers and month and day of birth (MMDD) will be submitted to CPE Monitor for official record of credit.

Contact:

For questions about your CE certificate, contact: edeshields@healthfederation.org           

For any other questions or comments about this activity, please contact: CEServices@academycme.org

Intended Audience

Pharmacists and pharmacy technicians interested in an overview of hepatitis A, hepatitis B, and hepatitis C viruses, including current hepatitis A and hepatitis B vaccination recommendations, and service integration considerations including infrastructure and billing. Pharmacy professionals who are in the process of planning, implementing, or modifying current practices around hepatitis A, B and C services are encouraged to join.  

Contact